The article highlights key funding news in the healthcare and technology sectors, emphasizing the importance of lesser-known stories amidst a flood of daily news. Notable developments include HepaRegeniX's €21.5M financing for liver disease therapies, Skin Analytics securing €17.4M to enhance its teledermatology services for cancer detection, and Mila raising €12M to innovate in the insurance sector. Additionally, SAE received a €10M loan focused on advancing sustainable energy projects. These narratives underscore the ongoing investment and advancements aimed at addressing crucial health and environmental challenges in today's society.
HepaRegeniX plans to use the proceeds to complete its ongoing Phase Ib trial and to advance the Phase IIa clinical trial for HRX-215, the company's lead clinical candidate in liver regeneration.
Skin Analytics has seen more than 150,000 NHS patients and detected more than 14,000 cancers through its teledermatology services, significantly aiding in cancer survival.
Mila, an ACPR-approved French insurer, raised €12M to reinforce its innovative insurance model, merging brokerage, insurance, digital, and property expertise.
SAE aims to develop sustainable energy projects, including facilitating the Afon Wysg 1 Battery Storage Project with the €10M loan from the CCR.
Collection
[
|
...
]